首页> 美国卫生研究院文献>Diagnostic Pathology >IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis

【2h】

IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis

机译：IL-17A在桥本甲状腺炎并存的甲状腺乳头状癌患者中增加I类MHC表达并促进T细胞活化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe incidence of coexisting papillary thyroid cancer (PTC) and Hashimoto’s thyroiditis (HT) is increasing. The impact of HT on PTC prognosis and its possible mechanism remains controversial. Interleukin-17A (IL-17A) has been reported to participate in the pathogenesis of multiple autoimmune diseases and cancers. The aim of this study is to investigate the role of IL-17A in PTC with coexistent HT and evaluate the changes in tumor antigenicity.

机译：背景乳头状甲状腺癌（PTC）和桥本甲状腺炎（HT）并存的发生率正在增加。 HT对PTC预后及其可能机制的影响尚存争议。已报道白介素-17A（IL-17A）参与多种自身免疫性疾病和癌症的发病机制。这项研究的目的是调查IL-17A在PTC与HT共存中的作用，并评估肿瘤抗原性的变化。

著录项

期刊名称 Diagnostic Pathology
作者
Li-Tao Han; Jia-Qian Hu; Ben Ma; Duo Wen; Ting-Ting Zhang; Zhong-Wu Lu; Wen-Jun Wei; Yu-Long Wang; Yu WANG; Tian Liao; Qing-Hai Ji;
展开▼
作者单位

展开▼
年(卷),期 2019(14),-1
年度 2019
页码 52
总页数 10
原文格式 PDF
正文语种
中图分类病理学;
关键词
Papillary thyroid cancer Hashimoto’s thyroiditis Immune escape MHC class I molecule Interleukin-17A PD-1/PD-L1;

机译：甲状腺乳头状癌;桥本甲状腺炎;免疫逃逸;MHC I类分子;白介素17A;PD-1 / PD-L1;

相似文献

外文文献
中文文献
专利

1. IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro [J] . Jia-Qian Hu, Bo-Wen Lei, Duo Wen, Journal of Cancer . 2020,第14期

机译：IL-2增强的MHC I类I表达乳头状甲状腺癌与哈希莫氏症的甲状腺炎克服了免疫逃生体外
2. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients [J] . J. LIANG, W. ZENG, F. FANG, Acta Otorhinolaryngologica Italica . 2017,第5期

机译：桥本甲状腺炎合并乳头状甲状腺癌1392例临床分析
3. Dual inhibition of BRAF and MEK increases expression of sodium iodide symporter in patient-derived papillary thyroid cancer cells in vitro Discussion [J] . Doherty Gerard M., Ullmann Timothy M., Patel Kepal Surgery . 2020,第1期

机译：BRAF和MEK的双重抑制增加了碘化钠交响者在体外讨论中患者衍生的乳头状甲状腺癌细胞的表达
4. Exposure to Flame Retardant Chemicals in the Home and Increased Risk for Papillary Thyroid Cancer [C] . Kate Hoffman, Julie Ann Sosa, Amelia Lorenzo, Annual conference of the International Society of Exposure Science . 2016

机译：在家中接触阻燃化学品并增加乳头状甲状腺癌的风险
5. Central Lymph Node Dissection in Patients with Papillary Thyroid Cancer: A Population Level Analysis of 14,257 Cases. [D] . Enyioha, Chineme Ijeoma. 2013

机译：乳头状甲状腺癌患者的中央淋巴结清扫术：14,257例人群水平分析。
6. IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimotos thyroiditis overcomes immune escape in vitro [O] . Jia-Qian Hu, Bo-Wen Lei, Duo Wen, 2020

机译：IL-2增强桥本甲状腺炎的乳头状甲状腺癌中MHC I类表达克服了体外免疫逃逸
7. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis [O] . Li-Tao Han, Jia-Qian Hu, Ben Ma, 2019

机译：IL-17A增加MHC I类表达，促进乳头状甲状腺癌患者的T细胞活化，共存哈希莫氏菌炎

相关主题

IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis

摘要

著录项

相似文献

相关主题

期刊订阅